FGFR1 inhibition by carvacrol: A novel strategy for oral squamous cell carcinoma therapy
Saved in:
| Main Authors: | Shuzhen Xiang, Hongyan Zhang, Qian Wang, Jiajia Fan, Shiheng Jia, Lan Zhang, Wei Ma, Minda Liu, Yanshu Li, Wei Dai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-09-01
|
| Series: | Genes and Diseases |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304224002769 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sorafenib tosylate inhibits autophagy, proliferation and migration of oral squamous cell carcinoma
by: XIONG Jianzhe, et al.
Published: (2024-08-01) -
Knockdown of RFC4 inhibits cell proliferation of oral squamous cell carcinoma in vitro and in vivo
by: Pengyue You, et al.
Published: (2025-02-01) -
The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma
by: Wenjing Zhang, et al.
Published: (2020-01-01) -
Alterations in HMGB1, ROS1, FGFR1, FGFR2, IL6, and TLR4 are associated with worse survival in patients with esophageal squamous cell carcinoma
by: Victor C. Kok, et al.
Published: (2025-03-01) -
FBXW7 promotes autophagy and inhibits proliferation of oral squamous cell carcinoma
by: Bo Qiu, et al.
Published: (2023-05-01)